Canine Heterologous Platelet-Rich Plasma (PRP) for the Management of FHV-1 Associated Corneal Ulcers in Three Cats

Document Type : Original Article

Authors

1 Faculty of Veterinary Medicine, Semnan University, Semnan, Iran

2 Department of Clinical Sciences, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran

3 DVM student, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran,

4 DVM student, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran

10.22075/jvlr.2025.37879.1171

Abstract

Platelet-rich plasma (PRP) contains high concentrations of platelets and growth factors that promote tissue repair by stimulating angiogenesis, recruiting stem cells, and modulating cellular activity. Both autologous PRP (derived from the patient) and heterologous PRP (donor-derived from the same species) have been effective in treating corneal injuries such as keratitis and corneal erosions. Heterologous PRP, particularly when obtained from blood banks, provides an accessible alternative, and studies have confirmed its safety. This case series evaluated the use of canine-derived heterologous PRP in treating corneal ulcers in three FHV-1-infected kittens. Due to the unavailability of autologous PRP, dog-sourced PRP was used as adjunctive therapy alongside standard treatments (antibiotics, antivirals, and artificial tears). Clinical signs included symblepharon and corneal sequestra, with ultrasound confirming corneal edema and secondary uveitis. Significant improvement in ulcer healing suggested the potential efficacy of interspecies PRP. Unvaccinated kittens exhibited more severe disease, and in one case, conjunctival flap surgery was required due to owner non-compliance. The findings indicate that heterologous PRP, including interspecies preparations, may be a promising alternative when autologous PRP is unavailable. However, further research is needed to validate its safety and efficacy. Strict adherence to veterinary protocols remains essential to prevent complications and ensure optimal outcomes.
 

Keywords

Main Subjects


Acosta, L., Castro, M., Fernandez, M., Oliveres, E., Gomez-Demmel, E., & Tartara, L. (2014). Treatment of corneal ulcers with platelet rich plasma. Archivos de la Sociedad Española de Oftalmología (English Edition), 89(2), 48-52.
Akbarzadeh, S., McKenzie, M. B., Rahman, M. M., & Cleland, H. (2021). Allogeneic platelet-rich plasma: is it safe and effective for wound repair? European Surgical Research, 62(1), 1-9.
Alio, J. L., Abad, M., Artola, A., Rodriguez-Prats, J. L., Pastor, S., & Ruiz-Colecha, J. (2007). Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology, 114(7), 1286-1293. e1281.
Alizadeh, S., Balagholi, S., Baradaran-Rafii, A., Delfaza-Baher, S., Safi, S., Safi, H., Dabbaghi, R., & Kanavi, M. R. (2019). Autologous platelet-rich plasma eye drops accelerate re-epithelialization of post-keratoplasty persistent corneal epithelial defects. Journal of Ophthalmic & Vision Research, 14(2), 131.
AM Everts, P., M Hoogbergen, M., A Weber, T., JJ Devilee, R., van Monftort, G., & HJT de Hingh, I. (2012). Is the use of autologous platelet-rich plasma gels in gynecologic, cardiac, and general, reconstructive surgery beneficial? Current Pharmaceutical Biotechnology, 13(7), 1163-1172.
Chidambaram, J. D. (2007). Recent advances in the diagnosis and management of bacterial keratitis. International ophthalmology clinics, 47(3), 1-6.
Dean, E., & Meunier, V. (2013). Feline eosinophilic keratoconjunctivitis: a retrospective study of 45 cases (56 eyes). Journal of feline medicine and surgery, 15(8), 661-666.
Helps, C., Lait, P., Damhuis2, A., Björnehammar, U., Bolta, D., Brovida, C., Chabanne, L., Egberink, H., Ferrand, G., & Fontbonne, A. (2005). Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Veterinary Record, 156(21), 669-673.
Kim, K. M., Shin, Y.-T., & Kim, H. K. (2012). Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis. Japanese journal of ophthalmology, 56, 544-550.
Nasisse, M., Guy, J., Davidson, M., Sussman, W., & Fairley, N. (1989). Experimental ocular herpesvirus infection in the cat. Sites of virus replication, clinical features and effects of corticosteroid administration. Investigative ophthalmology & visual science, 30(8), 1758-1768.
Nasisse, M. P., English, R. V., Tompkins, M. B., Guy, J. S., & Sussman, W. (1995). Immunologic, histologic, and virologic features of herpesvirus-induced stromal keratitis in cats. American journal of veterinary research, 56(1), 51-55.
Nasisse, M. P., Guy, J. S., Stevens, J. B., English, R. V., & Davidson, M. G. (1993). Clinical and laboratory findings in chronic conjunctivitis in cats: 91 cases (1983–1991). Journal of the American Veterinary Medical Association, 203(6), 834-837.
Powell, C. C., McInnis, C. L., Fontenelle, J. P., & Lappin, M. R. (2010). Bartonella species, feline herpesvirus-1, and Toxoplasma gondii PCR assay results from blood and aqueous humor samples from 104 cats with naturally occurring endogenous uveitis. Journal of feline medicine and surgery, 12(12), 923-928.
Punduk, Z., Oral, O., Ozkayin, N., Rahman, K., & Varol, R. (2016). Single dose of intra-muscular platelet rich plasma reverses the increase in plasma iron levels in exercise-induced muscle damage: A pilot study. Journal of sport and health science, 5(1), 109-114.
Sánchez-González, D. J., Méndez-Bolaina, E., & Trejo-Bahena, N. I. (2012). Platelet‐rich plasma peptides: key for regeneration. International journal of peptides, 2012(1), 532519.
Sharun, K., Jambagi, K., Dhama, K., Kumar, R., & Pawde, A. (2021). Therapeutic potential of platelet-rich plasma in canine medicine. Archives of Razi Institute, 76(4), 721.
Tanidir, S. T., Yuksel, N., Altintas, O., Yildiz, D. K., Sener, E., & Caglar, Y. (2010). The effect of subconjunctival platelet-rich plasma on corneal epithelial wound healing. Cornea, 29(6), 664-669.